Petros Pharmaceuticals appoints Robert Weinstein chief accounting officer, principal financial officer

Petros Pharmaceuticals Inc Ordinary Shares

PTPI

0.00

Petros Pharmaceuticals separated from Vice President of Finance Mitchell Arnold, effective June 18, 2026.
Robert Weinstein was appointed chief accounting officer, principal financial officer, principal accounting officer, effective immediately.
Weinstein has over 30 years in accounting, investment banking, healthcare private equity, including CFO roles at TAO Synergies, Green Energy Management Services, Xcorporeal.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Petros Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-075849), on June 18, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.